Oncorus, Inc.·4

Oct 8, 6:33 PM ET

Nam Spencer 4

4 · Oncorus, Inc. · Filed Oct 8, 2020

Insider Transaction Report

Form 4
Period: 2020-10-06
Nam Spencer
Director
Transactions
  • Conversion

    Series B Preferred Stock

    2020-10-061,9240 total
    Common Stock (1,924 underlying)
  • Conversion

    Common Stock

    2020-10-06+1,9241,924 total
Footnotes (1)
  • [F1]Each share of Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION